Synonyms: Bexxar® | V10XA53
tositumomab is an approved drug (FDA (2003))
Compound class:
Antibody
Comment: Tositumomab was used as a radioimmunotherapy drug, targeting CD20 on B-lymphocytes prior to cessation of its manufacture.
|
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
non-Hodgkin lymphoma |
Disease Ontology:
DOID:0060060 OMIM: 605027 |
Approved for CD20 positive follicular non-Hodgkin's lymphoma but production/sales were ceased by the manufacturer in 2014. |